tert-Butyl 4-hydroxy-7,8-dihydropyrido[4',3':3,4]pyrazolo[1,5-a]pyrimidine-9(10H)-carboxylate
≥95%
- Product Code: 85460
CAS:
1624262-46-9
| Molecular Weight: | 290.32 g./mol | Molecular Formula: | C₁₄H₁₈N₄O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28125599 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of biologically active molecules. It plays a significant role in the development of potential therapeutic agents, particularly in the design of kinase inhibitors. These inhibitors are explored for their efficacy in treating various diseases, including cancer and inflammatory disorders. The structural features of this compound make it a valuable building block for creating complex heterocyclic compounds, which are often key components in drug discovery programs. Its application extends to research laboratories where it is used to study structure-activity relationships and optimize drug candidates for enhanced potency and selectivity.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $258.56 |
+
-
|
| 0.250 | 10-20 days | $516.67 |
+
-
|
tert-Butyl 4-hydroxy-7,8-dihydropyrido[4',3':3,4]pyrazolo[1,5-a]pyrimidine-9(10H)-carboxylate
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of biologically active molecules. It plays a significant role in the development of potential therapeutic agents, particularly in the design of kinase inhibitors. These inhibitors are explored for their efficacy in treating various diseases, including cancer and inflammatory disorders. The structural features of this compound make it a valuable building block for creating complex heterocyclic compounds, which are often key components in drug discovery programs. Its application extends to research laboratories where it is used to study structure-activity relationships and optimize drug candidates for enhanced potency and selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :